Lung Cancer

Results of trial SAKK 16/14: Neoadjuvant immunotherapy in locally advanced non-small cell lung cancer

The lay summaries with the interim results of the still ongoing study SAKK 16/14 are ready for dissemination to the participants and the public.

Results of trial SAKK 16/14: Neoadjuvant immunotherapy in locally advanced non-small cell lung cancer

The lay summaries with the interim results of the still ongoing study SAKK 16/14 are ready for dissemination to the participants and the public.

We are very grateful for the collaboration with our Patient Advisory Board. May these documents be a sign of gratitude to the participants of this important study in lung cancer.

Many thanks also to the Rising Tide Foundation for Clinical Cancer Research for funding the lay summary pilot project of SAKK. It is our ambition to serve the patients and the public with better information on our research.

More information and lay summaries

 

All News